SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 5th, 2018 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 29, 2017, by and between PROPANC BIOPHARMA, INC., a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124, Australia, (the “Company”), and EAGLE EQUITIES, LLC, a New York limited liability company, with its address at 91 Shelton Avenue, Suit 107, New Haven, CT 06511 (the “Buyer”).
